1402-1403 / 2351
Neck Dissection and Chemoradiation
Pros
“MND still appears to confer a
disease-free survival and overall
survival
advantage
with acceptably
low morbidity” …….in patients with
N2-3 disease undergoing CRT
BUT, do all patients with N2-3
disease need it?
Brizel D
et al.
Int J Rad Oncol Biol Phys 2004;58:1418